L. Koutsky
Epidemiology · 2002–2010
A researcher in the Science corpus: 7 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Epidemiology — 42 citations into it; #2,060 of 2,148 by trust here, #358 by citations
Whom L. Koutsky trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Koutsky overall
Papers from L. Koutsky's perspective
Ordered by how strongly the researchers L. Koutsky trusts endorse each paper. Same corpus, a different order for every researcher.
- HPV screening for cervical cancer in rural India. (New England Journal of Medicine)
- Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
- Nonparametric Estimation from Incomplete Observations
- Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (New England Journal of Medicine)
- iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
- Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. (The Lancet)
- Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. (Journal of the National Cancer Institute)
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. (Lancet. Infectious Diseases (Print))
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update (International Journal of Cancer)
Their papers
- Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. (2010) — 638 citations
- Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. (2007) — 2,030 citations
- Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions (2007) — 1,759 citations
- The epidemiology of human papillomavirus infections. (2005) — 1,089 citations
- Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. (2005) — 1,716 citations
- Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. (2003) — 6,450 citations
- A controlled trial of a human papillomavirus type 16 vaccine. (2002) — 1,817 citations